Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in JNJ — Johnson & Johnson

CIK 1179392 NEW YORK, NY
Back to JNJ Full portfolio

Position in JNJ

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$13,017,163
+$6,734,368 QoQ
Shares Held
53,253
+75.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Mar 31, 2026
CallValue
$10,682,028
CallShares
43,700
PutValue
$11,170,908
PutShares
45,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

TWO SIGMA INVESTMENTS, LP holds $1,148,943,923 across 14 Drug Manufacturers - General names. JNJ ranks #8 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BMY
Bristol Myers Squibb Co
 11,535,106 $699,604,178
2 NVO
Novo Nordisk A S
 6,286,501 $231,028,911
3 LLY
ELI LILLY & Co
 64,550 $59,371,153
4 AZN
Astrazeneca PLC
 203,026 $40,040,787
5 ABBV
AbbVie Inc.
 178,418 $38,804,130
6 AMGN
Amgen Inc
 71,680 $25,220,608
7 OGN
Organon & Co.
 3,137,020 $18,790,749
8 JNJ
Johnson & Johnson
This page 		53,253 $13,017,163

All Filings in JNJ

Export CSV
41 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,682,028 43,700
2026-03-31 $11,170,908 45,700
2026-03-31 $13,017,163 53,253
2025-12-31 $5,629,040 27,200
2025-12-31 $7,884,795 38,100
2025-12-31 $6,282,795 30,359
2025-09-30 $6,860,540 37,000
2025-09-30 $8,992,870 48,500
2025-09-30 $171,566,715 925,287
2025-06-30 $27,035,528 176,992
2025-03-31 $3,973,028 23,957
2024-12-31 $9,222,128 63,768
2024-06-30 $94,968,044 649,754
2024-03-31 $54,545,652 344,811
2023-12-31 $160,320,255 1,022,842
2023-09-30 $1,052,247 6,756
2023-06-30 $124,273,740 750,808
2023-03-31 $173,173,440 1,117,248
2022-12-31 $235,237,032 1,331,656
2022-09-30 $216,912,675 1,327,820
2022-06-30 $136,679,504 769,982
2022-03-31 $99,189,959 559,668
2021-12-31 $258,025,736 1,508,305
2021-12-31 $23,812,944 139,200
2021-12-31 $14,540,950 85,000
2021-09-30 $807,500 5,000
2021-09-30 $131,936,456 816,944
2021-09-30 $484,500 3,000
2021-06-30 $17,923,712 108,800
2021-06-30 $246,879,034 1,498,598
2021-06-30 $20,576,026 124,900
2021-03-31 $13,821,835 84,100
2021-03-31 $268,636,977 1,634,542
2021-03-31 $13,000,085 79,100
2020-12-31 $116,258,651 738,713
2020-09-30 $58,278,331 391,445
2020-09-30 $1,548,352 10,400
2020-09-30 $3,230,696 21,700
2020-06-30 $10,434,746 74,200
2020-06-30 $9,830,037 69,900
2020-06-30 $2,127,310 15,127

Report a Problem

Category
Description
Email (optional, for follow-up)